Suppr超能文献

左半结肠癌和右半结肠癌的多组学差异分析。

Analysis of multi-omics differences in left-side and right-side colon cancer.

作者信息

Huang Yanyi, Duanmu Jinzhong, Liu Yushu, Yan Mengyun, Li Taiyuan, Jiang Qunguang

机构信息

Department of Gastrointestinal Surgery, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.

Nanchang University, The Second Clinical Medicine College, Nanchang, Jiangxi, China.

出版信息

PeerJ. 2021 May 12;9:e11433. doi: 10.7717/peerj.11433. eCollection 2021.

Abstract

BACKGROUND

Colon cancer is one of the most common tumors in the digestive tract. Studies of left-side colon cancer (LCC) and right-side colon cancer (RCC) show that these two subtypes have different prognoses, outcomes, and clinical responses to chemotherapy. Therefore, a better understanding of the importance of the clinical classifications of the anatomic subtypes of colon cancer is needed.

METHODS

We collected colon cancer patients' transcriptome data, clinical information, and somatic mutation data from the Cancer Genome Atlas (TCGA) database portal. The transcriptome data were taken from 390 colon cancer patients (172 LCC samples and 218 RCC samples); the somatic mutation data included 142 LCC samples and 187 RCC samples. We compared the expression and prognostic differences of LCC and RCC by conducting a multi-omics analysis of each using the clinical characteristics, immune microenvironment, transcriptomic differences, and mutation differences. The prognostic signatures was validated using the internal testing set, complete set, and external testing set (GSE39582). We also verified the independent prognostic value of the signature.

RESULTS

The results of our clinical characteristic analysis showed that RCC had a significantly worse prognosis than LCC. The analysis of the immune microenvironment showed that immune infiltration was more common in RCC than LCC. The results of differential gene analysis showed that there were 360 differentially expressed genes, with 142 upregulated genes in LCC and 218 upregulated genes in RCC. The mutation frequency of RCC was generally higher than that of LCC. BRAF and KRAS gene mutations were the dominant genes mutations in RCC, and they had a strong mutual exclusion with APC, while APC gene mutation was the dominant gene mutation in LCC. This suggests that the molecular mechanisms of RCC and LCC differed. The 4-mRNA and 6-mRNA in the prognostic signatures of LCC and RCC, respectively, were highly predictive and may be used as independent prognostic factors.

CONCLUSION

The clinical classification of the anatomic subtypes of colon cancer is of great significance for early diagnosis and prognostic risk assessment. Our study provides directions for individualized treatment of left and right colon cancer.

摘要

背景

结肠癌是消化道最常见的肿瘤之一。对左侧结肠癌(LCC)和右侧结肠癌(RCC)的研究表明,这两种亚型在预后、结局以及对化疗的临床反应方面存在差异。因此,需要更好地理解结肠癌解剖亚型临床分类的重要性。

方法

我们从癌症基因组图谱(TCGA)数据库门户收集了结肠癌患者的转录组数据、临床信息和体细胞突变数据。转录组数据来自390例结肠癌患者(172例LCC样本和218例RCC样本);体细胞突变数据包括142例LCC样本和187例RCC样本。我们通过对LCC和RCC各自进行多组学分析,比较其临床特征、免疫微环境、转录组差异和突变差异,分析两者的表达和预后差异。使用内部测试集、完整集和外部测试集(GSE39582)对预后特征进行验证。我们还验证了该特征的独立预后价值。

结果

我们的临床特征分析结果显示,RCC的预后明显比LCC差。免疫微环境分析表明,免疫浸润在RCC中比在LCC中更常见。差异基因分析结果显示,有360个差异表达基因,其中LCC中有142个上调基因,RCC中有218个上调基因。RCC的突变频率总体上高于LCC。BRAF和KRAS基因突变是RCC中的主要基因突变,它们与APC存在强烈的相互排斥,而APC基因突变是LCC中的主要基因突变。这表明RCC和LCC的分子机制不同。LCC和RCC预后特征中的4个mRNA和6个mRNA分别具有高度预测性,可作为独立的预后因素。

结论

结肠癌解剖亚型的临床分类对早期诊断和预后风险评估具有重要意义。我们的研究为左右结肠癌的个体化治疗提供了方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a60d/8123232/05844564df35/peerj-09-11433-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验